COMMUNIQUÉS West-GlobeNewswire

EDAP Announces Withdrawal of 510(k) Application for Focal One® to be Followed by New Submission to Conform to FDA Review Rules
17/07/2017
New 510(k) With New Clinical Data to be Submitted for Focal One® Initial 510(k) to be submitted for Ablatherm Fusion® LYON, France, July 17, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in [...]
Ossur Hf : Transactions in relation to share buyback program
17/07/2017
A nnouncement from Össur hf. No. 50/2017 Reykjavík, 17 July 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to [...]
Sanofi : Disclosure of trading in own shares
17/07/2017
Reporting EN This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]
Sanofi : Déclaration des transactions sur actions propres
17/07/2017
Reporting FR This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]
Diaxonhit : mise en oeuvre du regroupement d'actions par 20 entre le 1er août et le 1er septembre 2017
17/07/2017
MISE EN OEUVRE DU REGROUPEMENT D'ACTIONS DIAXONHIT Regroupement d'actions par voie d'échange à raison de 1 action nouvelle regroupée contre 20 actions anciennes ; Début des opérations de regroupement : 1 er août 2017 ; [...]
Virbac : la croissance du chiffre d'affaires au deuxième trimestre rattrape en grande partie le recul du premier trimestre
17/07/2017
Virbac : la croissance du chiffre d'affaires au deuxième trimestre rattrape en grande partie le recul du premier trimestre Communiqué diffusé le 17 juillet 2017 Le chiffre d'affaires du Groupe au deuxième trimestre s' [...]
Virbac: second quarter sales growth largely offsets the decline in the first quarter
17/07/2017
Virbac: second quarter sales growth largely offsets the decline in the first quarter Public release - July 17, 2017 Virbac consolidated revenue in the second quarter amounted to €234.8 million, up sharply by +7.5% [...]
Solon Eiendom ASA : Primary insider notification
17/07/2017
(Oslo, Norway, 17 July 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Dukat AS) has today bought 25,000 shares in Solon Eiendom ASA at a price of NOK 19. Following this [...]
Solon Eiendom ASA : Primary insider notification
17/07/2017
(Oslo, Norway, 17 July 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 80,986 shares in Solon Eiendom ASA at a price of NOK 18,9888. Following [...]
Targovax ASA: Final result of the subsequent offering
17/07/2017
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE [...]
Five-Year Data Demonstrate InterStim(TM) Therapy Offers Sustained Long-Term Efficacy and Quality of Life Improvements for Overactive Bladder Patients
17/07/2017
The InterStim System is the Only Proven, Long-Term Sacral Neuromodulation Solution for Overactive Active Bladder DUBLIN - July 17, 2017 - Medtronic plc (NYSE: MDT) today announced that the InterStim(TM) system, which [...]
RedHill Biopharma Announces Last Patient Visit in BEKINDA® Phase II Study for IBS-D
17/07/2017
Top-line results are expected in September 2017 The randomized, double-blind, placebo-controlled Phase II study is evaluating the safety and efficacy of BEKINDA ® (RHB-102) 12 mg in 127 U.S. patients with diarrhea- [...]
Novo Nordisk A/S - Share repurchase programme
17/07/2017
Bagsværd, Denmark, 17 July 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
MITHRA SUBMITS MYRING(TM) FOR EUROPEAN MARKETING APPROVAL
17/07/2017
PRESS RELEASE mithra submits MYRING(TM) For EUROpean Marketing approval Myring(TM) regulatory approvals in Europe and the US expected in 2018 Regulatory s ubmission follows recent European GMP approval for Myring(TM) [...]
ABLYNX PROPOSES APPOINTMENT OF MRS HILDE WINDELS AS A NEW INDEPENDENT DIRECTOR
17/07/2017
GHENT, Belgium, 17 July 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced that Hilde Windels will be nominated as an Independent Non-Executive Director at the Company's forthcoming Special General [...]
L'Association internationale pour l'étude du cancer du poumon annonce la 18e Conférence mondiale IASLC sur le cancer du poumon
14/07/2017
La seule conférence mondiale axée uniquement sur le cancer du poumon regroupera des milliers de personnes au Japon DENVER, le 14 juillet 2017 (GLOBE NEWSWIRE) - L'Association internationale pour l'étude du cancer du [...]
Novartis confirms 5 year data for first and only fully-human IL-17A inhibitor Cosentyx® reinforcing sustained efficacy and safety profile in psoriasis
14/07/2017
5 year data from long-term Phase III extension study demonstrate sustained efficacy and safety of Cosentyx in patients with moderate-to-severe plaque psoriasis[1] Data planned to be presented at a key medical congress [...]
IBA SA : IBA - NOTIFICATION DE TRANSPARENCE
14/07/2017
IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 14 juillet 2017, 17h40 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]
IBA SA : IBA - TRANSPARENCY NOTIFICATION
14/07/2017
IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, July 14, 2017, 5.40 p.m. - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that [...]

Pages